Rise in falls, infections linked to private equity-owned hospitals … Health workers spar over N95 mask guidance … Modifiable risk factors linked to higher risk for young-onset dementia … H. pylori...
Clinical briefs for Tuesday, Sept. 26
By
Kristen Fischer
Sep 26, 2023
COVID-19 drug linked to SARS-CoV-2 mutations … Study finds hormonal, immune differences in people with long COVID … Biomarker could spot Parkinson’s, related diseases early … CDC: In 2021, sepsis...
Clinical briefs for Friday, Aug. 4
By
Kristen Fischer
Aug 04, 2023
How race may affect memory care … Watch out for aortic stenosis in people with rheumatoid arthritis … Past trauma tied to poor health in older adults … Immunity’s role in neurodegeneration, aging
Also in the News for Monday, May 22
By
Kimberly Marselas
May 22, 2023
Therapy providers can continue to bill for some telehealth services the same way they did during the
public health emergency, CMS explains … Congressman, SEIU head call out ‘systemic racism’...
Non-drug therapies shown to cut fatigue in rheumatoid arthritis
By
Alicia Lasek (f3)
Jun 29, 2022
Physical therapy programs and cognitive behavioral health approaches help ease disabling fatigue in inflammatory rheumatic disorders, investigators say.
Healthy lifestyle cuts rheumatoid arthritis risk
Feb 07, 2022
Substantial proportion of overall risk may be preventable by healthy lifestyle
MRI of hand, foot may predict RA in undifferentiated arthritis
Jan 24, 2022
MRI-detected tenosynovitis independently associated with progression to rheumatoid arthritis
Air pollution linked to increased rheumatoid arthritis severity
Nov 02, 2021
C-reactive protein levels increased in association with higher concentrations of air pollutants; risk for flare increased
Arthritis drug Actemra in short supply as demand for use in COVID ramps up
By
Alicia Lasek
Aug 18, 2021
Demand for Actemra IV has skyrocketed due to the latest wave of COVID-19 infections and hospitalizations, drugmaker Genentech says. In the past two weeks alone, orders for the drug shot up to 400% of pre-COVID...
Risk factors ID’d for VTE, ASCVD in rheumatoid arthritis patients
Jul 23, 2021
Risk for atherosclerotic cardiovascular disease increased twofold after unprovoked VTE in rheumatoid arthritis